Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 131,534 | 117,085 | 109,332 | 92,761 | 93,401 |
| Cost of Goods | 6,094 | 3,211 | 1,699 | 1,265 | 1,557 |
| Gross Profit | 125,440 | 113,874 | 107,633 | 91,496 | 91,844 |
| Operating Expenses | 130,042 | 106,393 | 99,571 | 106,249 | 135,071 |
| Operating Income | -4,508 | 7,692 | 8,761 | -14,488 | -42,670 |
| Interest Expense | 24,449 | 24,828 | 24,733 | 24,506 | 24,583 |
| Other Income | 2,966 | 3,689 | 3,470 | 3,980 | 4,091 |
| Pre-tax Income | -25,991 | -13,447 | -12,502 | -35,014 | -63,162 |
| Income Tax | 804 | 586 | 172 | 365 | -1,431 |
| Net Income Continuous | -26,795 | -14,033 | -12,674 | -35,379 | -61,731 |
| Net Income | $-26,795 | $-14,033 | $-12,674 | $-35,379 | $-61,731 |
| EPS Basic Total Ops | -0.13 | -0.07 | -0.06 | -0.17 | -0.31 |
| EPS Basic Continuous Ops | -0.13 | -0.07 | -0.06 | -0.17 | -0.31 |
| EPS Diluted Total Ops | -0.13 | -0.07 | -0.06 | -0.17 | -0.31 |
| EPS Diluted Continuous Ops | -0.13 | -0.07 | -0.06 | -0.17 | -0.31 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.07 | -0.06 | N/A | N/A |
| EBITDA(a) | $-6,959 | $5,964 | $5,588 | $-17,363 | $-45,696 |